Clinical Trials Directory

Trials / Terminated

TerminatedNCT05807750

Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults

Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults: A Randomized, Controlled, 300-Subject Clinical Trial

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
AltaMed Health Services Corporation · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

Unplanned 30-day hospital readmissions are an critical healthcare quality metric, with meaningful effects on patients and health systems operations. Interventions to reduce unplanned readmissions have primarily operated within a healthcare-centric frame, with enhancements to either pre- or post-discharge care planning, medication reconciliation, or visit frequency. Associations of 30-day readmission rates with poverty status and other social factors, however, suggest that attending to unmet social needs may yield added benefits to models focused on healthcare delivery. The purpose of the present trial is to provide evidence regarding the effects on 30-day readmissions of providing a one-time post-discharge income supplement to socially vulnerable older adults with medical complexity participating in an enhanced care coordination program.

Conditions

Interventions

TypeNameDescription
OTHERPost-discharge income supplement$300 income supplement
OTHEREnhanced care planningEnhanced care planning provided by a nurse care manager

Timeline

Start date
2023-06-21
Primary completion
2024-04-22
Completion
2024-04-22
First posted
2023-04-11
Last updated
2024-06-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05807750. Inclusion in this directory is not an endorsement.